Literature DB >> 19681934

Implant-supported electrostimulating device to treat xerostomia: a preliminary study.

Smidt Ami1, Andy Wolff.   

Abstract

BACKGROUND: The full accomplishment of salivary function depends on proper salivary flow rate and composition. Salivary secretion is highly essential in the maintenance of health and integrity of oral hard and soft tissue. Xerostomia is a common symptom affecting between one-fifth and one-third of the adult population, more commonly women than men. Induction of salivary secretion exists in several pharmacological formulations per os. Electrostimulation to enhance salivary secretion has been used frequently as a research tool but only in limited extent as a clinical method to treat patients with xerostomia.
PURPOSE: The aims of this preliminary study were to observe and evaluate the therapeutic effect on xerostomia of the Saliwell Crown (Saliwell Ltd., Harutzim, Israel), an innovative saliva electrostimulation device fixed on an implant, placed in the lower third molar area.
MATERIALS AND METHODS: A Saliwell Crown was placed in the lower third molar area of an 81-year-old female patient with complaints of dry and burning mouth. Salivary secretion was measured, and the patient was asked to fill in written satisfaction questionnaires. The patient was monitored for a year, comparing her salivary secretion rates and the written questionnaires.
RESULTS: The results showed a constant slight but significant increase in the salivary secretion and in the patient's personal feelings as presented in the questionnaires.
CONCLUSIONS: The saliva stimulation device Saliwell Crown, placed on an implant in an 81-year-old patient with dry and burning mouth complaints, presented promising results when both the salivary secretion tests and the self-assessment questionnaires were examined and compared.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19681934     DOI: 10.1111/j.1708-8208.2009.00180.x

Source DB:  PubMed          Journal:  Clin Implant Dent Relat Res        ISSN: 1523-0899            Impact factor:   3.932


  5 in total

Review 1.  [Current therapeutic options in Sjögren's syndrome].

Authors:  A Hansen; T Dörner
Journal:  Z Rheumatol       Date:  2010-02       Impact factor: 1.372

Review 2.  Dental implants in patients affected by systemic diseases.

Authors:  N Donos; E Calciolari
Journal:  Br Dent J       Date:  2014-10       Impact factor: 1.626

3.  An imaging-based approach to the evaluation of xerostomia.

Authors:  Steven Duong; Joseph Youssef; Paloma Pimenta; Holly Aguigam; Jun Zhang; Alden Calantog; Shira Pilch; James G Masters; Petra Wilder-Smith
Journal:  Lasers Surg Med       Date:  2012-06-12       Impact factor: 4.025

Review 4.  Cost-effectiveness landscape analysis of treatments addressing xerostomia in patients receiving head and neck radiation therapy.

Authors:  Laura S Sasportas; Drew N Hosford; Maria A Sodini; Dale J Waters; Elizabeth A Zambricki; Joëlle K Barral; Edward E Graves; Todd J Brinton; Paul G Yock; Quynh-Thu Le; Davud Sirjani
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2013-05-03

Review 5.  Therapeutic Strategies for Dry Mouth Management with Emphasis on Electrostimulation as a Treatment Option.

Authors:  Amela Tulek; Aida Mulic; Martine Hogset; Tor Paaske Utheim; Amer Sehic
Journal:  Int J Dent       Date:  2021-10-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.